Identification of key molecular pathways and genes in BRCA1 and BRCA2-mutant ovarian cancer: evidence from bioinformatics analysis-Reference-Cited by-同舟云学术

Identification of key molecular pathways and genes in BRCA1 and BRCA2-mutant ovarian cancer: evidence from bioinformatics analysis

Published:2024-07-12 Issue:4 Volume:5 Page:164-182
ISSN:2524-7662
Container-title:Genome Instability & Disease
language:en
Short-container-title:GENOME INSTAB. DIS.

Author:

Awaji Aeshah A.,Maigoro Abdulkadir Yusif,Aborode Abdullahi Tunde,Akintola Ashraf Akintayo,Fatoba Dorcas Oladayo,Idris Einass Babikir,Idris Abeer Babiker,Jafri Saman,Shoaib Ekram,Onifade Isreal Ayobami,Olapade Zainab,Oladayo Modupe,Ihemegbulem Ifeyinwa Anne,Ipede Oluwaseun,Idowu Abidemi Ruth,Alabi Funke V.,Aruorivwooghene Ibude Jane,Enaworu Oghenetanure Ryan,Jamiu Abdullahi,Bakre Adetolase A.,Kwon Hyung Wook,Hwang Ui Wook,Adesola Ridwan Olamilekan^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42764-024-00133-9.pdf

Reference72 articles.

1. ACOG Committee on Practice Bulletins. (2009). Hereditary breast and ovarian cancer syndrome. Gynecologic Oncology 113(1):6–11. https://doi.org/10.1016/j.ygyno.2009.02.017

2. Amendola, L. M., Jarvik, G. P., Leo, M. C., McLaughlin, H. M., Akkari, Y., Amaral, M. D., Berg, J. S., Biswas, S., Bowling, K. M., Conlin, L. K., et al. (2016). Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. American Journal of Human Genetics, 98(6), 1067–1076. https://doi.org/10.1016/j.ajhg.2016.03.024

3. Atipairin, A., Canyuk, B., & Ratanaphan, A. (2011). The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs. Breast Cancer Research and Treatment, 126(1), 203–209. https://doi.org/10.1007/s10549-010-1182-7

4. Ayi, T. C., Tsan, J. T., Hwang, L. Y., Bowcock, A. M., & Baer, R. (1998). Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein. Oncogene, 17(16), 2143–2148.

5. Bates, K. M., Vathiotis, I., MacNeil, T., Ahmed, F. S., Aung, T. N., Katlinskaya, Y., & Gavrielatou, N. (2023). Spatial characterization and quantification of CD40 expression across cancer types. BMC Cancer, 23(1), 1–10.